| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.936 | 0.003 | 0.936 | Anticoagulant | 0.883 0.004 CID_107669 | ||
| 0.809 | 0.003 | 0.809 | Thrombin inhibitor | 0.588 0.003 CID_107669 | ||
| 0.789 | 0.002 | 0.789 | Trypsin inhibitor | 0.616 0.003 CID_107669 | ||
| 0.773 | 0.003 | 0.773 | Factor X inhibitor | 0.478 0.004 CID_107669 | ||
| 0.752 | 0.002 | 0.752 | Trypsin I inhibitor | 0.605 0.003 CID_107669 | ||
| 0.722 | 0.002 | 0.722 | Plasmin inhibitor | 0.554 0.003 CID_107669 | ||
| 0.635 | 0.005 | 0.635 | Platelet antagonist | 0.629 0.005 CID_107669 | ||
| 0.564 | 0.02 | 0.564 | Antithrombotic | 0.553 0.022 CID_107669 | ||
| 0.537 | 0.005 | 0.598 | Platelet adhesion inhibitor | 0.598 0.004 CID_107669 | CID_107669 | |
| 0.525 | 0.004 | 0.572 | NMDA 2 receptor antagonist | 0.572 0.003 CID_107669 | CID_107669 | |
| 0.511 | 0.003 | 0.511 | Plasminogen activator inhibitor | 0.22 0.004 CID_107669 | ||
| 0.509 | 0.009 | 0.509 | Platelet aggregation inhibitor | 0.41 0.017 CID_107669 | ||
| 0.502 | 0.003 | 0.502 | Kallikrein 1 inhibitor | 0.253 0.004 CID_107669 | ||
| 0.51 | 0.012 | 0.51 | Superoxide dismutase inhibitor | 0.395 0.028 CID_107669 | ||
| 0.476 | 0.012 | 0.476 | Sigma receptor agonist | 0.357 0.029 CID_107669 | ||
| 0.457 | 0.003 | 0.457 | Tryptase inhibitor | 0.334 0.003 CID_107669 | ||
| 0.479 | 0.031 | 0.479 | 5 Hydroxytryptamine release stimulant | 0.183 0.138 CID_107669 | ||
| 0.411 | 0.004 | 0.411 | Nav1.1 sodium channel blocker | 0.291 0.009 CID_107669 | ||
| 0.4 | 0.008 | 0.446 | Hemostatic | 0.446 0.005 CID_107669 | CID_107669 | |
| 0.372 | 0.007 | 0.372 | Butyrylcholinesterase inhibitor | 0.133 0.041 CID_107669 | ||
| 0.35 | 0.003 | 0.35 | Factor VIIa inhibitor | 0.249 0.004 CID_107669 | ||
| 0.367 | 0.026 | 0.367 | Anticonvulsant | 0.194 0.087 CID_107669 | ||
| 0.343 | 0.005 | 0.36 | NMDA receptor antagonist | 0.36 0.005 CID_107669 | CID_107669 | |
| 0.351 | 0.016 | 0.351 | Tyrosine 3 hydroxylase inhibitor | 0.22 0.104 CID_107669 | ||
| 0.342 | 0.011 | 0.342 | Nav1.2 sodium channel blocker | 0.211 0.031 CID_107669 | ||
| 0.334 | 0.01 | 0.334 | Acetylcholine M1 receptor antagonist | 0.314 0.012 CID_107669 | ||
| 0.306 | 0.004 | 0.306 | Factor Xa inhibitor | 0.16 0.008 CID_107669 | ||
| 0.297 | 0.004 | 0.297 | Nitric-oxide synthase inhibitor | 0.166 0.017 CID_107669 | ||
| 0.291 | 0.005 | 0.291 | GP IIb/IIIa receptor antagonist | 0.151 0.01 CID_107669 | ||
| 0.333 | 0.058 | 0.333 | Aldehyde oxidase inhibitor | 0.247 0.083 CID_107669 | ||
| 0.277 | 0.003 | 0.277 | 5 Hydroxytryptamine 3 agonist | 0.115 0.01 CID_107669 | ||
| 0.288 | 0.016 | 0.314 | Cholinergic antagonist | 0.314 0.013 CID_107669 | CID_107669 | |
| 0.277 | 0.005 | 0.277 | CXC chemokine 4 receptor antagonist | 0.142 0.017 CID_107669 | ||
| 0.281 | 0.011 | 0.326 | Acetylcholine muscarinic antagonist | 0.326 0.007 CID_107669 | CID_107669 | |
| 0.285 | 0.015 | 0.311 | Acetylcholine antagonist | 0.311 0.013 CID_107669 | CID_107669 | |
| 0.257 | 0.005 | 0.257 | HIV-1 integrase (Overall Integration) inhibitor | 0.21 0.01 CID_107669 | ||
| 0.374 | 0.125 | 0.374 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.269 0.258 CID_107669 | ||
| 0.352 | 0.108 | 0.361 | Analgesic | 0.361 0.102 CID_107669 | CID_107669 | |
| 0.354 | 0.112 | 0.354 | 5 Hydroxytryptamine release inhibitor | 0.267 0.205 CID_107669 | ||
| 0.238 | 0.009 | 0.238 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.247 | 0.019 | 0.247 | Sodium channel blocker | 0.135 0.069 CID_107669 | ||
| 0.228 | 0.004 | 0.228 | NMDA 2A receptor antagonist | 0.102 0.013 CID_107669 | ||
| 0.25 | 0.031 | 0.25 | Tumour necrosis factor antagonist | |||
| 0.223 | 0.004 | 0.223 | Urokinase inhibitor | 0.169 0.005 CID_107669 | ||
| 0.253 | 0.04 | 0.253 | P-glycoprotein inhibitor | 0.187 0.073 CID_107669 | ||
| 0.213 | 0.003 | 0.261 | Sphingosine kinase 2 inhibitor | 0.261 0.002 CID_107669 | CID_107669 | |
| 0.205 | 0.006 | 0.205 | Neurotensin receptor antagonist | 0.113 0.012 CID_107669 | ||
| 0.262 | 0.07 | 0.262 | Interleukin agonist | 0.226 0.097 CID_107669 | ||
| 0.193 | 0.008 | 0.193 | Interleukin 2 antagonist | 0.141 0.023 CID_107669 | ||
| 0.193 | 0.014 | 0.193 | Histidine decarboxylase inhibitor | 0.157 0.018 CID_107669 | ||
| 0.195 | 0.017 | 0.195 | 5 Hydroxytryptamine 3A agonist | |||
| 0.228 | 0.053 | 0.228 | Non-steroidal antiinflammatory agent | 0.172 0.094 CID_107669 | ||
| 0.218 | 0.044 | 0.218 | Thrombolytic | 0.188 0.058 CID_107669 | ||
| 0.183 | 0.009 | 0.183 | Sigma receptor antagonist | |||
| 0.195 | 0.034 | 0.195 | Anesthetic local | 0.139 0.054 CID_107669 | ||
| 0.182 | 0.024 | 0.182 | Antihistaminic | |||
| 0.174 | 0.021 | 0.201 | Protein kinase C gamma inhibitor | 0.201 0.014 CID_107669 | CID_107669 | |
| 0.176 | 0.023 | 0.176 | Histamine antagonist | |||
| 0.155 | 0.004 | 0.232 | Sphingosine kinase inhibitor | 0.232 0.003 CID_107669 | CID_107669 | |
| 0.153 | 0.004 | 0.153 | Histamine H4 receptor antagonist | 0.052 0.028 CID_107669 | ||
| 0.258 | 0.11 | 0.328 | Interleukin 2 agonist | 0.328 0.056 CID_107669 | CID_107669 | |
| 0.156 | 0.009 | 0.156 | Acetylcholine M4 receptor antagonist | 0.066 0.062 CID_107669 | ||
| 0.239 | 0.093 | 0.239 | 5 Hydroxytryptamine uptake stimulant | 0.224 0.111 CID_107669 | ||
| 0.277 | 0.132 | 0.277 | GABA C receptor rho-3 antagonist | 0.214 0.19 CID_107669 | ||
| 0.203 | 0.058 | 0.203 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.168 | 0.028 | 0.168 | GABA C receptor agonist | 0.133 0.042 CID_107669 | ||
| 0.154 | 0.014 | 0.154 | Analgesic, opioid | 0.138 0.017 CID_107669 | ||
| 0.16 | 0.022 | 0.16 | AMP-activated protein kinase stimulant | 0.152 0.027 CID_107669 | ||
| 0.242 | 0.104 | 0.242 | Insulysin inhibitor | 0.189 0.174 CID_107669 | ||
| 0.14 | 0.004 | 0.14 | Factor XIa inhibitor | 0.088 0.007 CID_107669 | ||
| 0.174 | 0.04 | 0.174 | Sodium channel (voltage-gated) blocker | |||
| 0.181 | 0.049 | 0.181 | Neurotensin receptor agonist | |||
| 0.146 | 0.017 | 0.146 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CID_107669 | ||
| 0.147 | 0.02 | 0.153 | Protein kinase C zeta inhibitor | 0.153 0.019 CID_107669 | CID_107669 | |
| 0.134 | 0.01 | 0.134 | Acetylcholine M5 receptor antagonist | 0.06 0.042 CID_107669 | ||
| 0.158 | 0.034 | 0.158 | Antiadrenergic | |||
| 0.126 | 0.008 | 0.126 | Kallikrein inhibitor | 0.061 0.023 CID_107669 | ||
| 0.197 | 0.079 | 0.197 | Neurotrophic factor enhancer | |||
| 0.136 | 0.02 | 0.136 | Histamine N-methyltransferase inhibitor | 0.077 0.07 CID_107669 | ||
| 0.122 | 0.007 | 0.129 | Protein kinase C beta inhibitor | 0.129 0.005 CID_107669 | CID_107669 | |
| 0.16 | 0.049 | 0.16 | Acetylcholinesterase inhibitor | |||
| 0.115 | 0.004 | 0.115 | Calcium channel P-type blocker | 0.099 0.005 CID_107669 | ||
| 0.119 | 0.011 | 0.119 | Maillard reaction inhibitor | 0.114 0.012 CID_107669 | ||
| 0.128 | 0.023 | 0.128 | Glutamate (mGluR7) agonist | 0.09 0.084 CID_107669 | ||
| 0.116 | 0.011 | 0.116 | NMDA 2C receptor antagonist | |||
| 0.283 | 0.179 | 0.364 | Cyclophilin D inhibitor | 0.364 0.112 CID_107669 | CID_107669 | |
| 0.108 | 0.004 | 0.108 | Dopamine D5 agonist | 0.055 0.014 CID_107669 | ||
| 0.139 | 0.035 | 0.139 | Nav1.5 sodium channel blocker | |||
| 0.107 | 0.004 | 0.166 | Sphingosine kinase 1 inhibitor | 0.166 0.003 CID_107669 | CID_107669 | |
| 0.146 | 0.046 | 0.146 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.209 | 0.11 | 0.209 | Cardiotonic | |||
| 0.11 | 0.012 | 0.11 | Alpha 2 adrenoreceptor agonist | |||
| 0.109 | 0.013 | 0.109 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.162 | 0.068 | 0.162 | Cholinergic | |||
| 0.101 | 0.007 | 0.101 | Lysine-specific demethylase 1A inhibitor | |||
| 0.151 | 0.058 | 0.151 | Bone formation stimulant | |||
| 0.097 | 0.004 | 0.097 | Trypsin II inhibitor | 0.075 0.005 CID_107669 | ||
| 0.099 | 0.007 | 0.099 | Factor VII inhibitor | 0.061 0.01 CID_107669 | ||
| 0.135 | 0.048 | 0.135 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.09 | 0.005 | 0.09 | Plasma kallikrein inhibitor | 0.041 0.018 CID_107669 | ||
| 0.149 | 0.064 | 0.151 | Adenylate cyclase stimulant | 0.151 0.061 CID_107669 | CID_107669 | |
| 0.129 | 0.044 | 0.129 | GABA C receptor antagonist | |||
| 0.092 | 0.009 | 0.092 | Epithelial sodium channel blocker | |||
| 0.084 | 0.005 | 0.084 | Factor XI inhibitor | 0.04 0.016 CID_107669 | ||
| 0.083 | 0.004 | 0.083 | Phenylethanolamine N methyltransferase inhibitor | 0.049 0.016 CID_107669 | ||
| 0.091 | 0.012 | 0.091 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.104 | 0.028 | 0.104 | Glutamate decarboxylase inhibitor | 0.084 0.04 CID_107669 | ||
| 0.08 | 0.005 | 0.08 | Acid-sensing ion channel blocker | 0.048 0.018 CID_107669 | ||
| 0.117 | 0.042 | 0.119 | Factor V inhibitor | 0.119 0.04 CID_107669 | CID_107669 | |
| 0.079 | 0.005 | 0.079 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.223 | 0.151 | 0.223 | Vasodilator, peripheral | |||
| 0.131 | 0.059 | 0.131 | 5 Hydroxytryptamine antagonist | |||
| 0.197 | 0.125 | 0.197 | Neuropeptide Y2 antagonist | |||
| 0.115 | 0.045 | 0.115 | GABA C receptor rho-1 antagonist | |||
| 0.089 | 0.023 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 CID_107669 | CID_107669 | |
| 0.164 | 0.099 | 0.164 | Anesthetic general | |||
| 0.13 | 0.065 | 0.13 | Glutamate receptor antagonist | 0.119 0.075 CID_107669 | ||
| 0.069 | 0.005 | 0.069 | Lysine carboxypeptidase inhibitor | 0.046 0.009 CID_107669 | ||
| 0.082 | 0.023 | 0.082 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.067 | 0.01 | 0.067 | Nicotinamide phosphoribosyltransferase inhibitor | |||
| 0.113 | 0.057 | 0.113 | Electron transport complex I inhibitor | |||
| 0.112 | 0.057 | 0.112 | Aminopeptidase B inhibitor | 0.098 0.066 CID_107669 | ||
| 0.105 | 0.05 | 0.105 | Prolactin inhibitor | |||
| 0.064 | 0.009 | 0.064 | Guanylate cyclase inhibitor | 0.043 0.029 CID_107669 | ||
| 0.101 | 0.047 | 0.101 | Alpha 2 adrenoreceptor antagonist | |||
| 0.062 | 0.008 | 0.062 | Nerve growth factor antagonist | |||
| 0.056 | 0.005 | 0.056 | Bradykinin B2 receptor antagonist | 0.052 0.006 CID_107669 | ||
| 0.123 | 0.071 | 0.123 | Cathepsin H inhibitor | 0.109 0.09 CID_107669 | ||
| 0.076 | 0.026 | 0.076 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.111 | 0.06 | 0.111 | Ferrochelatase inhibitor | 0.094 0.078 CID_107669 | ||
| 0.093 | 0.043 | 0.093 | Opioid kappa receptor antagonist | |||
| 0.058 | 0.009 | 0.058 | Histamine H1 receptor agonist | |||
| 0.103 | 0.056 | 0.121 | Creatine kinase inhibitor | 0.121 0.041 CID_107669 | CID_107669 | |
| 0.088 | 0.042 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.071 | 0.025 | 0.229 | NMDA 2B receptor antagonist | 0.229 0.005 CID_107669 | CID_107669 | |
| 0.069 | 0.024 | 0.069 | Opioid agonist | 0.057 0.032 CID_107669 | ||
| 0.071 | 0.026 | 0.071 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.068 | 0.023 | 0.068 | Bcl-xL inhibitor | |||
| 0.107 | 0.063 | 0.107 | DOPA decarboxylase inhibitor | |||
| 0.06 | 0.018 | 0.06 | Factor III inhibitor | 0.047 0.044 CID_107669 | ||
| 0.135 | 0.094 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 CID_107669 | CID_107669 | |
| 0.094 | 0.053 | 0.094 | Opioid antagonist | |||
| 0.065 | 0.024 | 0.065 | 5 Hydroxytryptamine 7 agonist | |||
| 0.092 | 0.051 | 0.092 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.069 | 0.029 | 0.096 | Protein kinase C eta inhibitor | 0.096 0.018 CID_107669 | CID_107669 | |
| 0.133 | 0.094 | 0.133 | Neuropeptide Y1 antagonist | |||
| 0.088 | 0.049 | 0.088 | Histamine H2 receptor antagonist | |||
| 0.095 | 0.057 | 0.095 | Adrenaline antagonist | |||
| 0.209 | 0.172 | 0.209 | Ca(v)3.3 blocker | |||
| 0.051 | 0.015 | 0.051 | Membrane dipeptidase inhibitor | 0.04 0.027 CID_107669 | ||
| 0.095 | 0.06 | 0.095 | Alpha adrenoreceptor antagonist | |||
| 0.071 | 0.036 | 0.071 | Acetylcholine M2 receptor antagonist | |||
| 0.05 | 0.015 | 0.05 | Bradykinin antagonist | |||
| 0.059 | 0.027 | 0.059 | Dipeptidyl peptidase inhibitor | |||
| 0.056 | 0.023 | 0.056 | Histamine H3 receptor antagonist | |||
| 0.073 | 0.043 | 0.073 | Alpha adrenoreceptor agonist | |||
| 0.047 | 0.017 | 0.047 | Arginase inhibitor | 0.036 0.026 CID_107669 | ||
| 0.047 | 0.017 | 0.047 | Vascular adhesion protein 1 inhibitor | |||
| 0.04 | 0.011 | 0.042 | Protein kinase C beta II inhibitor | 0.042 0.01 CID_107669 | CID_107669 | |
| 0.073 | 0.045 | 0.073 | CXC chemokine receptor antagonist | |||
| 0.036 | 0.008 | 0.036 | Estrogen-related receptor gamma antagonist | 0.033 0.01 CID_107669 | ||
| 0.217 | 0.189 | 0.217 | Calcium channel activator | |||
| 0.09 | 0.062 | 0.09 | Glutamate release inhibitor | |||
| 0.109 | 0.082 | 0.109 | MAO inhibitor | |||
| 0.113 | 0.085 | 0.213 | Alpha-N-acetylglucosaminidase inhibitor | 0.213 0.03 CID_107669 | CID_107669 | |
| 0.082 | 0.055 | 0.082 | Histamine H1 receptor antagonist | |||
| 0.072 | 0.046 | 0.072 | 5 Hydroxytryptamine agonist | |||
| 0.061 | 0.035 | 0.061 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.049 | 0.022 | 0.049 | Dipeptidyl peptidase IV inhibitor | |||
| 0.039 | 0.014 | 0.039 | Carboxypeptidase B inhibitor | 0.033 0.023 CID_107669 | ||
| 0.046 | 0.021 | 0.046 | NMDA receptor subunit 3A antagonist | |||
| 0.056 | 0.032 | 0.056 | Histamine agonist | |||
| 0.06 | 0.036 | 0.097 | Argininosuccinate synthase inhibitor | 0.097 0.02 CID_107669 | CID_107669 | |
| 0.06 | 0.038 | 0.064 | Neuropeptide agonist | 0.064 0.037 CID_107669 | CID_107669 | |
| 0.129 | 0.107 | 0.129 | GABA C receptor rho-2 antagonist | |||
| 0.029 | 0.009 | 0.029 | Integrin beta5 antagonist | 0.025 0.011 CID_107669 | ||
| 0.143 | 0.123 | 0.167 | Psychostimulant | 0.167 0.102 CID_107669 | CID_107669 | |
| 0.047 | 0.027 | 0.047 | Dopamine D5 antagonist | |||
| 0.039 | 0.02 | 0.039 | Opioid delta receptor agonist | |||
| 0.036 | 0.017 | 0.039 | Protein kinase C beta I inhibitor | 0.039 0.01 CID_107669 | CID_107669 | |
| 0.045 | 0.027 | 0.045 | Histamine H2 receptor agonist | |||
| 0.041 | 0.022 | 0.041 | Diamine oxidase inhibitor | |||
| 0.036 | 0.018 | 0.036 | Dipeptidyl peptidase II inhibitor | |||
| 0.071 | 0.056 | 0.071 | Alpha 2a adrenoreceptor antagonist | |||
| 0.175 | 0.16 | 0.225 | DNA synthesis inhibitor | 0.225 0.088 CID_107669 | CID_107669 | |
| 0.062 | 0.047 | 0.062 | Glucagon-like peptide 1 agonist | |||
| 0.069 | 0.055 | 0.079 | Aminopeptidase I inhibitor | 0.079 0.043 CID_107669 | CID_107669 | |
| 0.047 | 0.033 | 0.047 | Melanocortin antagonist | |||
| 0.024 | 0.01 | 0.024 | Melatonin 3 antagonist | |||
| 0.099 | 0.085 | 0.099 | Adenylate cyclase inhibitor | 0.099 0.085 CID_107669 | ||
| 0.08 | 0.068 | 0.08 | mTOR complex 2 inhibitor | |||
| 0.058 | 0.045 | 0.062 | Ryanodine receptor antagonist | 0.062 0.033 CID_107669 | CID_107669 | |
| 0.21 | 0.197 | 0.21 | Antiobesity | |||
| 0.023 | 0.011 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.045 | 0.033 | 0.045 | Farnesyltransferase inhibitor | |||
| 0.038 | 0.027 | 0.038 | Melanocortin 1 antagonist | |||
| 0.039 | 0.028 | 0.039 | AMPA 4 receptor antagonist | |||
| 0.029 | 0.018 | 0.029 | 5 Hydroxytryptamine 6 agonist | |||
| 0.043 | 0.032 | 0.043 | NMDA receptor subunit 3B antagonist | |||
| 0.075 | 0.065 | 0.075 | Glycine receptor antagonist | 0.073 0.07 CID_107669 | ||
| 0.044 | 0.035 | 0.044 | Opioid mu receptor agonist | |||
| 0.043 | 0.035 | 0.095 | Mannosidase inhibitor | 0.095 0.006 CID_107669 | CID_107669 | |
| 0.018 | 0.011 | 0.023 | Sodium/hydrogen exchanger inhibitor | 0.023 0.006 CID_107669 | CID_107669 | |
| 0.02 | 0.013 | 0.02 | Integrin beta3 antagonist | |||
| 0.07 | 0.063 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.049 | 0.042 | 0.049 | Protein kinase C epsilon inhibitor | |||
| 0.093 | 0.087 | 0.093 | Nav1.4 sodium channel blocker | |||
| 0.037 | 0.031 | 0.037 | 5 Hydroxytryptamine 2B agonist | |||
| 0.121 | 0.116 | 0.121 | Thiol protease inhibitor | |||
| 0.047 | 0.043 | 0.067 | Factor IXa inhibitor | 0.067 0.022 CID_107669 | CID_107669 | |
| 0.042 | 0.039 | 0.042 | Glycine transporter inhibitor | |||
| 0.066 | 0.063 | 0.067 | Glycine receptor agonist | 0.067 0.061 CID_107669 | CID_107669 | |
| 0.122 | 0.119 | 0.122 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.037 | 0.035 | 0.037 | Oxytocin agonist | |||
| 0.059 | 0.057 | 0.08 | Neuraminidase (influenza) inhibitor | 0.08 0.025 CID_107669 | CID_107669 | |
| 0.01 | 0.009 | 0.01 | Melatonin 5 antagonist | |||
| 0.114 | 0.113 | 0.114 | Diuretic | |||
| 0.054 | 0.053 | 0.054 | 5 Hydroxytryptamine 2A agonist | |||
| 0.023 | 0.022 | 0.023 | Melanocortin 5 antagonist | |||
| 0.051 | 0.053 | 0.067 | Acetylcholine M3 receptor antagonist | 0.067 0.034 CID_107669 | CID_107669 | |
| 0.136 | 0.138 | 0.168 | Phospholipase C inhibitor | 0.168 0.076 CID_107669 | CID_107669 | |
| 0.047 | 0.05 | 0.086 | Alpha-mannosidase inhibitor | 0.086 0.009 CID_107669 | CID_107669 | |
| 0.049 | 0.056 | 0.084 | Carbamoyl phosphate synthetase inhibitor | 0.084 0.027 CID_107669 | CID_107669 | |
| 0.109 | 0.117 | 0.125 | Cell wall synthesis inhibitor | 0.125 0.093 CID_107669 | CID_107669 | |
| 0.04 | 0.05 | 0.062 | Ornithine carbamoyltransferase inhibitor | 0.062 0.03 CID_107669 | CID_107669 | |
| 0.081 | 0.095 | 0.087 | Anabolic | 0.087 0.085 CID_107669 | CID_107669 | |
| 0.069 | 0.085 | 0.075 | MAP kinase kinase 7 inhibitor | 0.075 0.064 CID_107669 | CID_107669 | |
| 0.031 | 0.054 | 0.106 | Acetyl-CoA carboxylase inhibitor | 0.106 0.004 CID_107669 | CID_107669 | |
| 0.077 | 0.1 | 0.098 | Expectorant | 0.098 0.071 CID_107669 | CID_107669 | |
| 0.05 | 0.074 | 0.075 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.042 CID_107669 | CID_107669 | |
| 0.1 | 0.126 | 0.125 | Peroxidase inhibitor | 0.125 0.095 CID_107669 | CID_107669 | |
| 0.042 | 0.069 | 0.068 | Neuraminidase inhibitor | 0.068 0.035 CID_107669 | CID_107669 | |
| 0.017 | 0.048 | 0.027 | Bradykinin B2 receptor agonist | 0.027 0.021 CID_107669 | CID_107669 | |
| 0.081 | 0.114 | 0.122 | Adenylate kinase inhibitor | 0.122 0.042 CID_107669 | CID_107669 | |
| 0.036 | 0.071 | 0.065 | Alcohol oxidase inhibitor | 0.065 0.032 CID_107669 | CID_107669 | |
| 0.01 | 0.048 | 0.077 | Acetyl-CoA carboxylase 2 inhibitor | 0.077 0.004 CID_107669 | CID_107669 | |
| 0.031 | 0.07 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 CID_107669 | CID_107669 | |
| 0.106 | 0.147 | 0.129 | Growth hormone agonist | 0.129 0.109 CID_107669 | CID_107669 | |
| 0.03 | 0.078 | 0.052 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 CID_107669 | CID_107669 | |
| 0.051 | 0.1 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.052 CID_107669 | CID_107669 | |
| 0.036 | 0.087 | 0.067 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.067 0.028 CID_107669 | CID_107669 | |
| 0.039 | 0.091 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 CID_107669 | CID_107669 | |
| 0.035 | 0.087 | 0.059 | Biliverdin reductase inhibitor | 0.059 0.041 CID_107669 | CID_107669 | |
| 0.075 | 0.128 | 0.093 | Mucolytic | 0.093 0.088 CID_107669 | CID_107669 | |
| 0.031 | 0.084 | 0.052 | Acyl-CoA dehydrogenase inhibitor | 0.052 0.041 CID_107669 | CID_107669 | |
| 0.063 | 0.124 | 0.091 | Triose-phosphate isomerase inhibitor | 0.091 0.059 CID_107669 | CID_107669 | |
| 0.185 | 0.248 | 0.293 | Antibacterial | 0.293 0.14 CID_107669 | CID_107669 | |
| 0.063 | 0.127 | 0.098 | NADH dehydrogenase inhibitor | 0.098 0.046 CID_107669 | CID_107669 | |
| 0.034 | 0.103 | 0.067 | Phosphofructokinase-1 inhibitor | 0.067 0.05 CID_107669 | CID_107669 | |
| 0.143 | 0.217 | 0.171 | RNA-directed DNA polymerase inhibitor | 0.171 0.15 CID_107669 | CID_107669 | |
| 0.148 | 0.226 | 0.182 | Gastrin inhibitor | 0.182 0.176 CID_107669 | CID_107669 | |
| 0.115 | 0.195 | 0.209 | Immunostimulant | 0.209 0.115 CID_107669 | CID_107669 | |
| 0.021 | 0.117 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.03 CID_107669 | CID_107669 | |
| 0.11 | 0.215 | 0.162 | Spasmolytic | 0.162 0.152 CID_107669 | CID_107669 | |
| 0.054 | 0.162 | 0.093 | UDP-glucose 4-epimerase inhibitor | 0.093 0.069 CID_107669 | CID_107669 | |
| 0.136 | 0.261 | 0.168 | Nitric-oxide synthase stimulant | 0.168 0.158 CID_107669 | CID_107669 | |
| 0.124 | 0.289 | 0.228 | Peptidyltransferase inhibitor | 0.228 0.068 CID_107669 | CID_107669 | |
| 0.073 | 0.394 | 0.165 | Hypoglycemic | 0.165 0.155 CID_107669 | CID_107669 | |
| 0.02 | 0.439 | 0.412 | Ca(v)3.2 blocker | 0.412 0.002 CID_107669 | CID_107669 | |
| 0.016 | 0.674 | 0.158 | Nitric oxide antagonist | 0.158 0.089 CID_107669 | CID_107669 | |
| 0.025 | 0.795 | 0.291 | Antiinflammatory | 0.291 0.223 CID_107669 | CID_107669 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |